Last reviewed · How we verify
NCT05921552
Senior Adult Hepatobiliary Prehab Study
NA trial testing Resistance Training in Hepatobiliary Cancer in 25 participants. Participants enrolled and being followed up; not accepting new ones.
19 November 2026
Quick facts
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 25 |
| Start date | 26 June 2023 |
| Primary completion | 19 November 2026 |
| Estimated completion | 19 November 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Resistance Training
- Aerobic Training
Conditions studied
- Hepatobiliary Cancer — all drugs for Hepatobiliary Cancer →
- Cholangiocarcinoma — all drugs for Cholangiocarcinoma →
- Liver Metastases — all drugs for Liver Metastases →
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Who can join
65 and older, any sex, with Hepatobiliary Cancer or Cholangiocarcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate an exercise program for individuals with hepatobiliary cancer planning for surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exercise and Nutrition Interventions for Prehabilitation in Hepato-Pancreato-Biliary Cancers: A Narrative Review.
Christopher CN, Kang DW, Wilson RL, Gonzalo-Encabo P, et al · · 2023 · cited 13× · PMID 38140303 · DOI 10.3390/nu15245044
Verify or expand the search:
- PubMed search for NCT05921552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance Training
Trials testing the same drug.
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT07278440 — An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregi · NA · not yet recruiting
- NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
- NCT07262931 — Effect Of Sensory Motor Training Versus Resistance Training Among Individuals With Knee Osteoarthritis. · NA · not yet recruiting
- NCT07045727 — Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Olde · NA · recruiting
Other recruiting trials for Hepatobiliary Cancer
Currently open trials in the same condition.
- NCT06260943 — Targeted Navigation in Hepatocellular Carcinoma (HCC) · NA · recruiting
- NCT05724563 — Domvanalimab and Zimberelimab in Advanced Liver Cancers · Phase 2 · active not recruiting
- NCT04498767 — Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) · NA · recruiting
Other H. Lee Moffitt Cancer Center and Research Institute trials
Trials by the same sponsor.
- NCT05041335 — Wet Heparinized Suction for Abdominal Cancer · NA · not yet recruiting
- NCT07222995 — Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs · NA · recruiting
- NCT06047977 — Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors · Phase 1 · recruiting
- NCT06121180 — Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · Phase 2 · recruiting
- NCT06193486 — Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05921552 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute
- Last refreshed: 4 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05921552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing